In contrast, our data suggest that an Selleck Enzalutamide effect of Co and Cr on human primary osteoclasts occurs within the clinically observed concentration range and varies with cell maturity. At systemic levels these ions may have a mild stimulatory effect on developing osteoclasts, but at higher concentrations and in mature osteoclasts their effect is inhibitory. The reason for this difference might be explained by the substrate resorbing activity of the exposed cell, as mature resorbing osteoclasts may

accumulate more intracellular metal ions through phagocytic activity versus developing osteoclasts, and thus learn more demonstrate a greater toxic effect due to greater internalisation of the metal. In support of the increased resorption transient seen in the serum range, Patntirapong et al. have shown that cobalt ions in solution or incorporated into calcium phosphate coated plastic at clinically-relevant concentrations increase murine osteoclast differentiation and resorption in-vitro [23]. Whilst cobalt ions do not localise to bone, chromium salts do have an affinity for bone [24],

being trapped in the bone matrix, and thus levels in the bone microenvironment may exceed those found in serum. Albrecht et al. have also suggested a possible indirect route for osteoclast activation in response to Rutecarpine metal ions, showing that exposure of human peripheral blood mononuclear cells to Co2+ ions in-vitro results in upregulation of IL-1α, IL-1β, and IL-6 expression, that may

in turn increase osteoclast birth rate and resorption [25]. Differences in the cellular responses to Co2+, Cr3+, and Cr6+ are likely complex, with several mechanisms operating. Co2+ and Cr6+ ion complexes are highly soluble and readily cross cell membranes via the anion transporter, whilst Cr3+ complexes are less soluble at physiological pH and cell membrane permeability to Cr3+ is low [26]. These physico-chemical characteristics may explain, in part, the lower toxicity of Cr3+ relative to the other ions to both osteoblasts and osteoclasts. The high toxicity of Cr6+ may be explained by its rapid transport across cell membranes and subsequent reduction to Cr3+ within the cell by glutathione resulting in an increase in oxidative stress leading to cell death [27]. It is currently unclear which chromium species are released from prosthesis surfaces after MOMHR. Metal ion release as a result of corrosion, distinct to that arising from the process of wear, has been identified as a significant contributor to systemic metal release after MOMHR [7] and [28].